Microfluidic Chip Mimicking Tumor Microvasculature for Drug Delivery Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing in-vitro tumor drug delivery models fail to accurately predict drug delivery to tumors due to their inability to replicate the complex physico-chemical properties and microvascular environment of tumors, which differ significantly from normal tissues.
Innovation Solution
A microfluidic device with an optically clear chip containing a microvascular network of interconnected flow channels coated with endothelial cells, mimicking tumor microvasculature, is used to screen drug delivery vehicles, accounting for geometric and flow properties, increased permeability, and interstitial pressures, allowing for the evaluation of their ability to reach and permeate tumor cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If simple in-vitro models are used, then device complexity is reduced, but measurement precision deteriorates due to inability to capture complex tumor microvasculature phenomena
Solution Approach 1:
The patent creates a microfluidic device that copies the complex structure and function of tumor microvasculature, including branching networks, varying vessel diameters, and permeability characteristics. This physical replica enables accurate drug delivery prediction without requiring overly complex computational models, thus improving measurement precision while maintaining manageable device complexity.
Solution Approach 2:
The device incorporates adjustable parameters such as flow rates, pressure gradients, and pore sizes to simulate different tumor microvascular conditions. By changing these parameters, the same device can model various tumor types and stages, achieving high measurement precision across multiple scenarios without proportionally increasing device complexity.
2Measurement precision
If microfluidic device with endothelial cells and porous walls is used, then measurement precision improves by capturing tumor microvasculature properties, but device complexity increases
Solution Approach 1:
The device employs porous walls in the microchannels to simulate the leaky nature of tumor blood vessels. These porous structures allow controlled permeation of drug delivery vehicles, accurately replicating tumor microvascular permeability. This approach achieves high measurement precision through a relatively simple structural modification rather than complex multi-layer constructions.
Solution Approach 2:
Endothelial cells are cultured on the channel walls to self-organize and form functional barriers that naturally regulate permeability. The cells automatically respond to flow conditions and maintain physiological properties without requiring external control mechanisms, thus improving measurement precision while minimizing additional device complexity.
3Reliability
If physiologically realistic flow rates and shear forces are applied, then reliability of drug delivery evaluation improves, but use of energy increases
Solution Approach 1:
The device uses partial action by applying flow rates and shear forces that are sufficient to achieve reliable drug delivery evaluation without exceeding physiological ranges. This avoids excessive energy consumption while maintaining evaluation reliability, as the microfluidic scale naturally limits energy requirements compared to larger systems.
Solution Approach 2:
The system employs hydraulic principles to generate physiologically realistic flow conditions through pressure gradients. By using simple pressure differentials rather than complex pumping mechanisms, the device achieves reliable drug delivery evaluation at low energy consumption, leveraging natural fluid dynamics at the microscale.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the selection and optimization of drug delivery vehicles by simulating physiological conditions, improving the accuracy of tumor drug delivery models and enhancing the effectiveness of drug delivery to tumors.
Implementation Method 1
The microchannels are separated from the tissue space by pores in the walls of the channels having dimensions in the range of 0.2-5 μm to represent leaky vessels that allow transport of delivery vehicles across vascular walls
Implementation Method 2
Candidate drug delivery vehicles are introduced into and flowed through the flow channels of the device at physiologically realistic flow rates
Data Source
AI summary
An apparatus for assaying a tumor drug delivery vehicle and or drug can include an idealized microvascular network (IMN) of one or more interconnected idealized flow channels in fluid communication through a porous wall with a tissue space (e.g., idealized tissue space) containing animal cells and means for quantifying drug delivery through the IMN to the animal cells.